Article
Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Cutibacterium acnes Dominates the Post-Laser Skin Microbiome
Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
Tralokinumab Eases Joint Pain in Patients with AD
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Triveni Bio Launches First-in-Human Trial for TRIV-509 in Atopic Dermatitis
AC-201 Shows Strong Phase 2 Results in Psoriasis Trial